SAB Biotherapeutics, Inc.
SABS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001833214
No open-market purchases or sales by SAB Biotherapeutics, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $266.8M in total; no superinvestor holds it.
Other share classesSABSW
13F holders, Q4 2021
Institutional positions in SAB Biotherapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +33 vs. Q3 2021
- Shares held
- 3.10M
- +3.04M (+5,060.6%) vs. Q3 2021
- Total value
- $25.4M
- +$24.8M (+4,103.6%) vs. Q3 2021
- New holders
- 34
- 0 more added
- Sold out
- 1
- 0 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SABS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 87 | $266.8M |
| Q1 2026 | 76 | $265.0M |
| Q4 2025 | 48 | $135.9M |
| Q3 2025 | 34 | $56.3M |
| Q2 2025 | 25 | $3.37M |
| Q1 2025 | 26 | $2.99M |
| Q4 2024 | 25 | $10.1M |
| Q3 2024 | 25 | $8.48M |
| Q2 2024 | 22 | $9.69M |
| Q1 2024 | 24 | $15.2M |
| Q4 2023 | 42 | $24.5M |
| Q3 2023 | 34 | $2.41M |
| Q2 2023 | 38 | $3.28M |
| Q1 2023 | 39 | $1.71M |
| Q4 2022 | 38 | $2.42M |
| Q3 2022 | 40 | $2.32M |
| Q2 2022 | 37 | $4.45M |
| Q1 2022 | 27 | $6.71M |
| Q4 2021 | 34 | $25.4M |
| Q3 2021 | 1 | $605.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding SAB Biotherapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| First PREMIER Bank | 832,555 | $6.50M | 1.68% | +832,555 | New |
| Radcliffe Capital Management, L.P. | 546,658 | $5.52M | 0.20% | +546,658 | New |
| Vanguard Group Inc | 682,972 | $5.33M | 0.00% | +682,972 | New |
| Geode Capital Management, LLC | 293,406 | $2.29M | 0.00% | +293,406 | New |
| Shaolin Capital Management LLC | 239,750 | $1.87M | 0.05% | +239,750 | New |
| Institutional & Family Asset Management, LLC | 78,115 | $610.0K | 0.10% | +78,115 | New |
| BlackRock Inc. | 71,608 | $559.0K | 0.00% | +71,608 | New |
| Alps Advisors Inc | 50,306 | $393.0K | 0.00% | +50,306 | New |
| Northern Trust Corp | 44,476 | $347.0K | 0.00% | +44,476 | New |
| Veritable, L.P. | 43,551 | $340.0K | 0.01% | +43,551 | New |
| Morgan Stanley | 32,240 | $252.0K | 0.00% | +32,240 | New |
| Citadel Advisors LLC | 24,230 | $189.0K | 0.00% | +24,230 | New |
| Qube Research & Technologies Ltd | 16,817 | $131.0K | 0.00% | +16,817 | New |
| Virtu Financial LLC | 15,379 | $120.0K | 0.01% | +15,379 | New |
| Susquehanna International Group, LLP | 15,117 | $118.0K | 0.00% | +15,117 | New |
| Goldman Sachs Group Inc | 14,489 | $113.0K | 0.00% | +14,489 | New |
| ETF Managers Group, LLC | 13,202 | $105.0K | 0.00% | +13,202 | New |
| Cubist Systematic Strategies, LLC | 12,899 | $101.0K | 0.00% | +12,899 | New |
| State Street Corp | 12,300 | $96.0K | 0.00% | +12,300 | New |
| Nadler Financial Group, Inc. | 11,000 | $86.0K | 0.01% | +11,000 | New |
| Charles Schwab Investment Management Inc | 10,000 | $79.0K | 0.00% | +10,000 | New |
| Wolverine Asset Management LLC | 6,602 | $51.0K | 0.00% | +6,602 | New |
| UBS Group AG | 5,953 | $47.0K | 0.00% | +5,953 | New |
| Spectrum Management Group, LLC | 5,030 | $39.0K | 0.01% | +5,030 | New |
| JPMorgan Chase & Co | 3,832 | $30.0K | 0.00% | +3,832 | New |
| Penserra Capital Management LLC | 3,486 | $27.0K | 0.00% | +3,486 | New |
| Bank of America Corp | 2,174 | $16.0K | 0.00% | +2,174 | New |
| Royal Bank of Canada | 2,000 | $16.0K | 0.00% | +2,000 | New |
| Advisor Group Holdings, Inc. | 2,013 | $16.0K | 0.00% | +2,013 | New |
| Tower Research Capital LLC (TRC) | 1,565 | $12.0K | 0.00% | +1,565 | New |
| Citigroup Inc | 1,287 | $10.0K | 0.00% | +1,287 | New |
| Rockefeller Capital Management L.P. | 700 | $5.00K | 0.00% | +700 | New |
| Marshall Wace, LLP | 498 | $3.00K | 0.00% | +498 | New |
| Daiwa Securities Group Inc. | 127 | $1.00K | 0.00% | +127 | New |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |